Uterine Artery Embolization for Symptomatic Fibroids

This study is currently recruiting participants.

Verified by University of Manitoba, July 2006

Sponsored by:	University of Manitoba
Information provided by:	University of Manitoba
ClinicalTrials.gov Identifier:	NCT00354471

Purpose

This study will evaluate the safety, efficacy , quality of life and patient satisfaction of uterine artery embolization for the treatment of symptomatic uterine fibroids. It will provide useful information in the development od guidelines in patient selection, procedural management and subsequent follow up.

Condition	Intervention	Phase
Uterine Fibroids Menorrhagia Adenomyosis	Procedure: Uterine Artery Embolization	Phase III

U.S. FDA Resources

Study Type:	Observational
Study Design:	Prospective
Official Title:	Short and Long Term Outcomes of Uterine Artery Embolization.

Eligibility

Ages Eligible for Study:	18 Years to 60 Years
Genders Eligible for Study:	Female

Criteria

Inclusion Criteria:

Symptoms related to the pressence of uterine fibroids serious enough to consider surgical options
Confirmation of fibroids by endovaginal and transabdominal ultrasound

Exclusion Criteria:

Pedunculated fibroids
Desire for fertility
Carcinoma of pelvic organs
Previous pelvic irradiation
Bleeding diathesis and vasculitis
History of allergiy to contrst medium

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00354471

Contacts

Contact: Richard S Boroditsky, MD	204-975-7723	sleeson@hsc.mb.ca
Contact: Shauna M Leeson, RN	204-975-7723	sleeson@hsc.mb.ca

Locations

Canada, Manitoba
Health Sciences Centre	Recruiting
Winnipeg, Manitoba, Canada, R3E 3P4

Sponsors and Collaborators

University of Manitoba

Investigators

Principal Investigator:

Richard S Boroditsky, MD

University of Manitoba

More Information

Canadian Association of Radiologists This link exits the ClinicalTrials.gov site

Study ID Numbers:	B2000 115
Study First Received:	July 19, 2006
Last Updated:	March 19, 2008
ClinicalTrials.gov Identifier:	NCT00354471
Health Authority:	Canada: Health Canada

Study placed in the following topic categories:

Genital Diseases, Female
Neoplasms, Connective and Soft Tissue
Myofibroma
Menstruation Disturbances
Uterine Hemorrhage
Adenomyosis

Connective Tissue Diseases
Uterine Diseases
Endometriosis
Menorrhagia
Hemorrhage
Leiomyoma

Additional relevant MeSH terms:

Neoplasms, Muscle Tissue
Neoplasms
Pathologic Processes
Neoplasms by Histologic Type
Neoplasms, Connective Tissue

ClinicalTrials.gov processed this record on January 14, 2009